Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06611020

Acronym

VITAL

Enrollment

600

Registered

2024-09-24

Start date

2020-01-01

Completion date

2027-01-31

Last updated

2024-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Intraepithelial Neoplasia

Keywords

HPV

Brief summary

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Detailed description

Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Treatment of HPV-related disease

Exclusion criteria

* Previous HPV vaccination

Design outcomes

Primary

Measure	Time frame
HPV recurrence	2 years

Countries

Italy

Contacts

Primary ContactGiorgio Bogani, ph.d.

giorgiobogani@yahoo.it651-296-9676

Outcome results